ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 109 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,334 | -74.7% | 565 | -64.4% | 0.00% | – |
| Q2 2023 | $44,713 | +212819.0% | 1,585 | +27.3% | 0.00% | – |
| Q1 2023 | $21 | -12.5% | 1,245 | +2.5% | 0.00% | – |
| Q4 2022 | $24 | -99.9% | 1,215 | -1.9% | 0.00% | – |
| Q3 2022 | $31,000 | -8.8% | 1,238 | +3.2% | 0.00% | – |
| Q2 2022 | $34,000 | -37.0% | 1,200 | +1.7% | 0.00% | – |
| Q1 2022 | $54,000 | -30.8% | 1,180 | -13.2% | 0.00% | -100.0% |
| Q4 2021 | $78,000 | -30.4% | 1,360 | -19.0% | 0.00% | 0.0% |
| Q3 2021 | $112,000 | +25.8% | 1,680 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $89,000 | – | 1,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |